180 results
8-K
EX-99.1
BCRX
Biocryst Pharmaceuticals Inc.
7 Dec 20
BioCryst Announces $325 Million of Funding from Royalty Pharma and Athyrium Capital Management
9:34am
opportunities in the global healthcare sector. Athyrium advises funds with over $3.7 billion in committed capital. The Athyrium team has substantial … . Athyrium invests across all healthcare verticals including biopharma, medical devices and products, healthcare focused services, and healthcare
8-K
EX-99.1
BCRX
Biocryst Pharmaceuticals Inc.
3 Sep 20
U.S. Government Exercises Option To Purchase Additional RAPIVAB® from BioCryst for Delivery to Strategic National Stockpile
7:06am
in a public health emergency.
“There is great concern for the potential impact on the healthcare system in general, and hospitals in particular … appreciate the opportunity to deliver more RAPIVAB to the SNS to hold as a supplement for public health authorities and healthcare facilitites that might
8-K
EX-99.1
BCRX
Biocryst Pharmaceuticals Inc.
2 Apr 20
BioCryst Appoints Anthony Doyle Chief Financial Officer
7:55am
for GE Healthcare’s $1.2 billion U.S. diagnostic imaging business and served as global program manager for GE Healthcare Solutions, a hospital … and healthcare outcomes-based consulting company. From 2012 to 2014, he was CFO of World Book, a Berkshire Hathaway company.
“Anthony is a seasoned, global
8-K
BCRX
Biocryst Pharmaceuticals Inc.
2 Apr 20
BioCryst Appoints Anthony Doyle Chief Financial Officer
7:55am
then led risk and pricing for GE Healthcare’s $1.2 billion U.S. diagnostic imaging business and served as global program manager for GE Healthcare … Solutions, a hospital and healthcare outcomes-based consulting company. From 2012 to 2014, he was CFO of World Book, a Berkshire Hathaway company.
Mr. Doyle
8-K
BCRX
Biocryst Pharmaceuticals Inc.
13 Jan 20
BioCryst to Provide Berotralstat and BCX9930 Program Updates at 38th Annual J.P. Morgan Healthcare Conference
6:32am
, an oral Factor D inhibitor for complement-mediated diseases, this week at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco. A copy … entitled “BioCryst to Provide Berotralstat and BXC9930 Program Updates at 38th Annual J.P. Morgan Healthcare Conference.”
SIGNATURE
Pursuant
8-K
EX-99.1
tzkidu9 ar
13 Jan 20
BioCryst to Provide Berotralstat and BCX9930 Program Updates at 38th Annual J.P. Morgan Healthcare Conference
6:32am
8-K
EX-99.1
cklnncf6sbn29am5kkc
8 Jan 24
Results of Operations and Financial Condition
7:02am
8-K
EX-99.1
3okrnj67r0bfxwkic
10 Jan 22
Results of Operations and Financial Condition
7:04am
425
libnm6wp0
11 Jun 18
Business combination disclosure
2:42pm
425
i37lxb 8uxdl5
11 Jun 18
Business combination disclosure
2:41pm
425
2qspv devhyndhhouj
22 Jan 18
Business combination disclosure
12:00am